Viewing Study NCT07106034

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 2:28 AM
Ignite Modification Date: 2025-12-28 @ 12:01 AM
Study NCT ID: NCT07106034
Status: NOT_YET_RECRUITING
Last Update Posted: 2025-08-12
First Post: 2025-07-30
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Standard Second-line Therapy With ONgericimab and TOripalimab in pMMR/MSS Colorectal Cancer: a Single-arm Phase II Trial
Sponsor: Shanghai Pudong Hospital
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Advanced Colorectal Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Toripalimab View
None Ongericimab View
None colorectal cancer View
None pMMR/MSS View